Arribas Maite, Solmi Marco, Thompson Trevor, Oliver Dominic, Fusar-Poli Paolo
Early Psychosis: Interventions and Clinical-Detection (EPIC) Lab, Department of Psychosis Studies, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, United Kingdom.
Department of Psychiatry, University of Ottawa, Ottawa, ON, Canada.
Front Psychiatry. 2022 Sep 23;13:976035. doi: 10.3389/fpsyt.2022.976035. eCollection 2022.
The impact of timing of antipsychotics and benzodiazepine treatment during a first episode of psychosis on clinical outcomes is unknown. We present a RECORD-compliant electronic health record cohort study including patients ( = 4,483, aged 14-35) with a primary diagnosis of any non-organic ICD-10 first episode of psychosis at SLAM-NHS between 2007 and 2017. The impact of antipsychotic timing (prescription > 1 week after a first episode of psychosis) was assessed on the primary outcome (risk of any psychiatric inpatient admission over 6 years), and secondary outcomes (cumulative duration of any psychiatric/medical/accident/emergency [A&E] admission over 6 years). The impact of prescribing benzodiazepine before antipsychotic at any point and of treatment patterns (antipsychotic alone, benzodiazepine alone, combination of antipsychotic with benzodiazepine) within the first week after a first episode of psychosis were also assessed. Survival analyses and zero-inflated negative binomial regressions, adjusted for core covariates, and complementary analyses were employed. Antipsychotic prescribed >1 week after a first episode of psychosis did not affect the risk of any psychiatric admission (HR = 1.04, 95% CI = 0.92-1.17, = 0.557), but increased the duration of any psychiatric (22-28%), medical (78-35%) and A&E (30-34%) admission (months 12-72). Prescribing benzodiazepine before antipsychotic at any point did not affect the risk of any psychiatric admission (HR = 1.03, 95% CI = 0.94-1.13, = 0.535), but reduced the duration of any psychiatric admission (17-24%, months 12-72), and increased the duration of medical (71-45%, months 12-72) and A&E (26-18%, months 12-36) admission. Prescribing antipsychotic combined with benzodiazepine within the first week after a first episode of psychosis showed better overall clinical outcomes than antipsychotic or benzodiazepine alone. Overall, delaying antipsychotic 1 week after a first episode of psychosis may worsen some clinical outcomes. Early benzodiazepine treatment can be considered with concomitant antipsychotic but not as standalone intervention.
在精神病首次发作期间,抗精神病药物和苯二氮䓬类药物治疗时机对临床结局的影响尚不清楚。我们开展了一项符合RECORD标准的电子健康记录队列研究,纳入了2007年至2017年间在SLAM-NHS初次诊断为任何非器质性ICD-10编码的精神病首次发作的患者(n = 4483,年龄14 - 35岁)。评估了抗精神病药物治疗时机(精神病首次发作后1周以上开具处方)对主要结局(6年内任何精神科住院风险)和次要结局(6年内任何精神科/内科/事故/急诊[A&E]住院的累积时长)的影响。还评估了在任何时间点先于抗精神病药物开具苯二氮䓬类药物的影响,以及精神病首次发作后第一周内的治疗模式(单独使用抗精神病药物、单独使用苯二氮䓬类药物、抗精神病药物与苯二氮䓬类药物联合使用)的影响。采用了生存分析和经核心协变量调整的零膨胀负二项回归分析以及补充分析。精神病首次发作后1周以上开具抗精神病药物并不影响任何精神科住院风险(HR = 1.04,95%CI = 0.92 - 1.17,P = 0.557),但增加了任何精神科(22 - 28%)、内科(78 - 35%)和A&E(30 - 34%)住院的时长(第12至72个月)。在任何时间点先于抗精神病药物开具苯二氮䓬类药物并不影响任何精神科住院风险(HR = 1.03,95%CI = 0.94 - 1.13,P = 0.535),但减少了任何精神科住院的时长(17 - 24%,第12至72个月),并增加了内科(71 - 45%,第12至72个月)和A&E(26 - 18%,第12至36个月)住院的时长。在精神病首次发作后第一周内联合使用抗精神病药物和苯二氮䓬类药物显示出比单独使用抗精神病药物或苯二氮䓬类药物更好的总体临床结局。总体而言,在精神病首次发作后推迟1周使用抗精神病药物可能会使一些临床结局恶化。可考虑早期使用苯二氮䓬类药物并同时使用抗精神病药物,但不作为单独的干预措施。